Our pH-sensitive binder design service provides a state-of-the-art platform for developing antibodies, peptides, and protein binders whose affinity and binding activity can be precisely tuned by pH conditions. These "smart" molecular binders enable environment-responsive targeting — binding strongly at physiological pH and releasing their targets under acidic conditions such as those found in tumor microenvironments, endosomes, or lysosomes. This approach enhances target specificity, drug delivery efficiency, and safety, making it highly valuable for biotherapeutic, diagnostic, and drug delivery applications.
pH gradients are central to physiology, from vesicle acidification to the acidic tumor microenvironment. While therapeutics have been developed to exploit these pH changes to modulate activity across different physiological environments, current approaches for generating pH-dependent binders, such as combinatorial histidine scanning and display-based selections, are largely empirical and often labor-intensive. There are two complementary principles and associated computational methods for designing pH-dependent binders: (i) introducing histidine residues adjacent to positively charged residues at binder-target interfaces to induce electrostatic repulsion and weaken binding at low pH, and (ii) introducing buried histidine-containing charged hydrogen-bonding networks in the binder core such that the protein is destabilized under acidic conditions.
Our integrated computational platform combines AI-powered design, constant-pH molecular dynamics, and structural energetics to provide precise, predictive, and customizable pH-responsive binders. Supported by our protein expression and validation capabilities, we accelerate translation from in silico design to functional prototype.
Our service leverages advanced computational modeling and AI-assisted protein engineering to create binders that respond dynamically to changes in environmental pH. By precisely tuning the protonation states of key residues within the binding interface, we enable proteins, antibodies, and peptides to bind tightly at neutral pH and release their targets under acidic or basic conditions—ideal for applications in targeted drug delivery, antibody recycling, tumor microenvironments, and endosomal release systems.
| Field | Examples |
| Antibody Engineering | pH-switchable antibodies for recycling or antigen release in acidic endosomes (similar to FcRn mechanism). |
| Targeted Drug Delivery | Smart ligand or antibody–drug conjugates that release cargo in acidic tumor or endosomal environments. |
| Biosensors | pH-responsive recognition elements for environmental or physiological monitoring. |
| Therapeutic Proteins | Reduced off-target effects via reversible binding in neutral vs. acidic conditions. |
| Receptor–Ligand Studies | Mechanistic analysis of pH-modulated protein–protein interactions. |
Our multidisciplinary team combines expertise in computational protein engineering, molecular dynamics, and biotherapeutics. We deliver pH-responsive binders tailored for your molecular targets-ensuring precise control over interaction, release, and recycling behavior. This service empowers next-generation biologic design, enabling smarter and more selective therapies and diagnostics.